Tag: non-keratinizing nasopharyngeal carcinoma

Home / non-keratinizing nasopharyngeal carcinoma

Categories

Penpulimab-kcqx is approved by the USFDA for non-keratinizing nasopharyngeal carcinoma

On April 23, 2025, the Food and Drug Administration sanctioned penpulimab-kcqx (Akeso Biopharma Co., Ltd.) in conjunction with cisplatin or carboplatin and gemcitabine for the initial treatment of peo...
non-keratinizing-nasopharyngeal-carcinoma

Scan the code